The Moderna vaccine will be administered to patients in the UK for the first time today.
The first doses of the jab will be administered at West Wales General Hospital in Carmarthen, and a total of 5,000 doses have been distributed to vaccination centers.
Moderna’s vaccine is the third to be approved for use in the UK and will be rolled out in conjunction with jabs from Pfizer-BioNTech and the University of Oxford-AstraZeneca.
The UK has bought 17 million doses of Moderna jab, enough for 8.5 million people, and the results from phase three suggest that the vaccine is 100% effective against severe cases of coronavirus.
Health Secretary Matt Hancock said: “I am delighted that we can start the UK launch of the Moderna vaccine in West Wales today.”
“The UK government has secured vaccines on behalf of the entire nation and the vaccination program has shown that our country is working together at its best.
“Three in five people across the UK have received at least one dose, and today we start with the third approved vaccine. Wherever you live, when you get the call, get the vaccine.”
Welsh Health Minister Vaughan Gething added that the introduction of a third vaccine “significantly increases our defenses against coronavirus and will help protect our most vulnerable.”
Scotland received its first batch of Moderna vaccines on Monday, and a Health Department spokesman has said the vaccine will be rolled out in England “as soon as possible this month.”
Vaccine Minister Nadhim Zahawi said yesterday that this jab will be deployed “around the third week of April.”
It has not been confirmed when Moderna’s deployment in Northern Ireland will begin.
According to Moderna, no serious safety problems have been identified among those who have taken his vaccine. Serious events after the first dose have included pain around the injection site, while some have reported fatigue, muscle pain, joint pain, and headaches after receiving the second dose.
Comes after an Oxford-AstraZeneca essay COVID-19 vaccine in children in the UK I was on hiatus while regular medications investigate a possible link between needle stick and rare blood clots in adults.
A spokesperson for the University of Oxford emphasized that there were “no safety concerns” with this specific study, but that more information was expected from the Medicines and Healthcare Products Regulatory Agency (MHRA).
A spokesman for the Department of Health and Welfare said: “No decisions have been made on whether to offer vaccinations to children.
“We will be guided by the advice of our experts on these issues, including the independent MHRA and the Joint Committee on Vaccines and Immunization.”
Over the weekend, it was reported that there had been 30 cases of blood clotting reported by the MHRA of more than 18 million AstraZeneca injection doses administered.
The MHRA confirmed that of those 30 people, seven had died as of March 24.
The World Health Organization maintains that the benefits of this vaccine outweigh any risks.
Adam Finn, a professor of pediatrics at the University of Bristol, said: “There are some things that are very clear. The first is that these cases are really very rare. The second is that the vaccines that are available and in use in the UK prevent COVID very effectively. “
He added: “In short, if you are currently offered a dose of Oxford-AstraZeneca vaccine, your chances of staying alive and well will increase if you get vaccinated and decrease if you don’t. “